PSA Today Mar 19: Bonds and downgrades sap market / Japan's cinema business / Suzuki under pressure / Hitachi Chemical's Life Sciences / M3's dividend – Nikkei -0.08%
Japan Market Comment by Pelham Smithers, Julie Boote, Joel Scheiman, and Lindsay WhippNikkei ¥21,566.85 (-¥17.65 / -0.08%); Topix ¥1,610.23 (-¥3.45 / -0.21%); ¥/$111.27
Tags: Zozo (3092 JT), Hitachi (6501 JT), Sony (6758 JT), Nintendo (7974 JT), Toho (9602 JT), Toei (9605 JT), Suzuki (7269 JT), Maruti Suzuki (MSIL IN), Hitachi Chemical (4217 JT), HC Advanced Therapeutics Solutions (pvt.), apceth Biopharma GmbH (pvt), Lonza (LONN SW), Takara Bio (4974 JT), Fujifilm Holdings (4901 JT), SanBio (4592 JP), Daiichi Sankyo (4568 JT), GlaxoSmithKline (GSK LN), Adaptimmune Therapeutics (ADAP US), Kyowa Hakko Kirin (4151 JT), M3 (2413 JT), Poletowin Pitcrew (3657 JT), NTT DoCoMo (9437 JT)
Main Points
• Downgrades and bond market strength sap equities
• Toho raises cinema ticket prices as Japan’s film business bucks the global trend
• Suzuki under pressure on India demand concerns
• Hitachi Chemical’s Life Science strategy
• M3 raises dividend to ¥7/share
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.